Article
Doxorubicin cardiotoxicity and target cells: a broader perspective
3 Mar 2016
Abstract excerpt
The cardiotoxicity of doxorubicin is becoming an interdisciplinary point of interest given a growing population of cancer survivors. The complex and not completely understood pathogenesis of this complication makes difficult to design successful preventive or curative measures. Although cardiomyocyte has been considered a classical cellular target, other cells including various types of undifferentiated cells are...
Topics
Join the communities discussing this publication.